Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
57.41
-0.10 (-0.17%)
At close: Jun 2, 2026
Market Cap7.74B +85.9%
Revenue (ttm)323.87M -40.8%
Net Income89.82M -54.2%
EPS0.66 -54.1%
Shares Out 134.87M
PE Ratio87.01
Forward PE61.73
Dividend0.45 (0.78%)
Ex-Dividend Daten/a
Volume2,441,519
Open57.50
Previous Close57.51
Day's Range55.56 - 58.00
52-Week Range29.99 - 68.50
Beta1.16
Analystsn/a
Price Targetn/a
Earnings DateSep 4, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 558
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 144.47 million, a decrease of -41.48%.

Financial Statements